Therapeutic Potential of Foldamers: From Chemical Biology Tools To Drug Candidates?
-
- Ranganath Gopalakrishnan
- Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden
-
- Andrey I. Frolov
- Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden
-
- Laurent Knerr
- Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden
-
- William J. Drury
- Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden
-
- Eric Valeur
- Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden
書誌事項
- 公開日
- 2016-07-29
- DOI
-
- 10.1021/acs.jmedchem.6b00376
- 公開者
- American Chemical Society (ACS)
この論文をさがす
収録刊行物
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 59 (21), 9599-9621, 2016-07-29
American Chemical Society (ACS)